Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Author： Miles David   Baselga José   Amadori Dino   Sunpaweravong Patrapim   Semiglazov Vladimir   Knott Adam   Clark Emma   Ross Graham   Swain Sandra  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.142, Iss.1, 2013-11, pp. : 89-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer

By Somlo G.   Martel C.   Lau S.   Frankel P.   Ruel C.   Gu L.   Hurria A.   Chung C.   Luu T.   Morgan R.   Leong L.   Koczywas M.   McNamara M.   Russell C.   Kane S.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 899-906

Springer Publishing Company

Access to resources Recommend Favorite

Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

By Hovey Elizabeth   de Souza Paul   Marx Gavin   Parente Phillip   Rapke Tal   Hill Andrew   Bonaventura Antonino   Michele Antony   Craft Paul   Abdi Ehtesham   Lloyd Andrew  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1233-1242

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer

By Yardley Denise A.   Daniel Davey   Stipanov Michael   Drosick D. Randolph   Mainwaring Mark   Peyton James   Shastry Mythili   Hainsworth John D.  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 865-871

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer

By Eatock M. M.   Tebbutt N. C.   Bampton C. L.   Strickland A. H.   Valladares-Ayerbes M.   Swieboda-Sadlej A.   Van Cutsem E.   Nanayakkara N.   Sun Y.-N.   Zhong Z. D.   Bass M. B.   Adewoye A. H.   Bodoky G.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 710-718

Oxford University Press

Access to resources Recommend Favorite